-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: keymaster@town.hall.org
Originator-Key-Asymmetric:
 MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq
 pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ==
MIC-Info: RSA-MD5,RSA,
 oVynjisB3ZOyPNmdfl7b6KDdHUrJVQK92iNr5hqNnuKCwvs/azPFqI3/N+e+zFNg
 FXgo68onUhH1Huq49l+CWg==

<IMS-DOCUMENT>0000319815-95-000005.txt : 19950428
<IMS-HEADER>0000319815-95-000005.hdr.sgml : 19950428
ACCESSION NUMBER:		0000319815-95-000005
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	19950131
FILED AS OF DATE:		19950427
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAXWELL LABORATORIES INC /DE/
		CENTRAL INDEX KEY:			0000319815
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				952390133
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10964
		FILM NUMBER:		95532043

	BUSINESS ADDRESS:	
		STREET 1:		8888 BALBOA AVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		6192795100

	MAIL ADDRESS:	
		STREET 2:		8888 BALBOA AVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
</IMS-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<TEXT>
 
 
  
  
                   SECURITIES AND EXCHANGE COMMISSION  
  
                        WASHINGTON, D. C. 20549  
  
		


                     FORM 10-Q (Amendment No. 1)
  
            QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE   
                   SECURITIES EXCHANGE ACT OF 1934  
  
For the Quarter Ended January 31, 1995      Commission file Number 0-10964  
  
                      MAXWELL LABORATORIES, INC.                  
	     
                    Delaware    IRS ID# 95-2390133      
                        8888 Balboa Avenue,
                     San Diego, California  92123       
                       Telephone  (619) 279-5100  
  
     Indicate by check mark whether the registrant (1) has filed 
all reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.  
  
  
                        YES [X]        NO [ ]  
  
     As of February 28, 1995 Registrant had only one class of common
stock of which there were 2,674,973 shares outstanding.


<PAGE>  
PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K  
         ________________________________
    
         (a)  Exhibits  
              ________
    
              Exhibit 27 - Financial Data Schedule

         (b)  Reports on Form 8-K  
              ___________________

              No reports on Form 8-K were filed during the quarter ended January
              31, 1995.


  
                               SIGNATURE  
  
Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.  
  
                                   MAXWELL LABORATORIES, INC.              
  

  
April 26, 1995                     Gary J. Davidson                
Date                               Gary Davidson, Chief Financial Officer     
                                      and Authorized Officer  
  
  
  
</TEXT> 


</DOCUMENT>

<DOCUMENT>
<TYPE>EX-27
<SEQUENCE>2
<DESCRIPTION>ARTICLE 5 FINANCIAL DATA SCHEDULE FOR 2ND QUARTER 10-Q
<TEXT>

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Condensed Balance Sheet and the Consolidated Condensed Statement
of Income as filed in Item 1 on Form 10-Q and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUL-31-1995
<PERIOD-END>                               JAN-31-1995
<CASH>                                           1,724
<SECURITIES>                                         0
<RECEIVABLES>                                   15,375
<ALLOWANCES>                                         0
<INVENTORY>                                      8,869
<CURRENT-ASSETS>                                29,858
<PP&E>                                          55,935
<DEPRECIATION>                                  35,239
<TOTAL-ASSETS>                                  51,924
<CURRENT-LIABILITIES>                           11,537
<BONDS>                                          2,341
<COMMON>                                           267
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      35,253
<TOTAL-LIABILITY-AND-EQUITY>                    51,924
<SALES>                                         35,548
<TOTAL-REVENUES>                                35,548
<CGS>                                           25,992
<TOTAL-COSTS>                                   25,992
<OTHER-EXPENSES>                                 2,290    
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    889
<INCOME-TAX>                                       284
<INCOME-CONTINUING>                                560
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       560
<EPS-PRIMARY>                                      .21
<EPS-DILUTED>                                      .21
        

</TABLE>
</TEXT>
</DOCUMENT>
</IMS-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----